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ABSTRACT
Aspergillus restrictus, an osmophilic fungus, is abundant in 
house dust. We have shown previously that the incidence of 
immediate hypersensitivity to A. restrictus is comparable to 
that for Aspergillus fumigatus and Alternaria alternata in 
asthmatic children. Radioallergosorbent test (RAST) inhibi-
tion was used to determine whether A. restrictus shares simi-
lar allergenic components with A. fumigatus and A. 
alternata. Mycelial mats of the three species cultivated on 
completely synthetic media were used for extract prepara-
tion. IgE antibodies to each fungus were measured with RAST 
using a polyvinyl chloride microplate as a solid phase. 
Analysis of a serum pool obtained from nine asthmatic chil-
dren with a positive RAST to A. restrictus showed that A. 
restrictus inhibited the RAST to A. restrictus, A. fumigatus and 
A. alternata by more than 80%. Similar results were observed 
with A. fumigatus and A. alternata. Additionally, when 13 
serum samples with a positive RAST to A. restrictus were 
tested separately, A. restrictus substantially inhibited the A. 
restrictus RAST in all subjects tested. A. fumigatus and A. 
alternata inhibited the A. restrictus RAST in 10 and 8 of the 
samples studied, respectively. These findings indicate that A. 
restrictus shares allergenic components with A. fumigatus and 
A. alternata. The allergenic cross-reactivity between A. fumi-
gatus and A. alternata was also demonstrated.
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INTRODUCTION
Household fungi may be significant causal agents of childhood 
asthma, particularly because young children tend to spend 
much of their time indoors. Recent mycological studies1-4 using 
culture media with low water activity (e. g. MA64,1 DG185) have 
shown that house dust contains many species of osmophilic 
fungi, one of the most common being Aspergillus restrictus. 
There is evidence that these osmophilic fungi, especially A. 
restrictus, grow well in house dust containing dry organic sub-
stances at normal levels of humidity.6-9
 We have shown previously that A. restrictus may act as an 
aeroallergen10 since IgE-mediated skin hypersensitivity to this 
fungus was demonstrated in asthmatic children by skin prick test 
and a radioallergosorbent test (PAST) using its mycelial extract. 
In addition, A. restrictus had a comparable incidence of positive 
skin prick tests and RAST to Aspergillus fumigatus and Alternaria 
alternata. A. restrictus, therefore, seems to play as important a 
role in childhood asthma as A. fumigatus and A. alternata. We 
observed significant correlations between the BAST values for 
A. restrictus and those for A. fumigatus and A. alternata in our 
previous study,10 providing circumstantial evidence for shared 
allergenic components in A. restrictus and the other species. 
Indeed, allergenic cross-reactivity was demonstrated between 
. restrictus and A. fumigatus in our previous study.11 We have 
now investigated whether A. restrictus shares allergens with 
A. alternata using BAST inhibition.
  We previously used an A. restrictus extract that was prepared 
from its mycelia) mat cultivated in an organic medium, M40Y, to 
investigate the cross-allergenicity between A. restrictus and 
A. fumigatus.11 In the present study, a completely synthetic 
defined medium, yeast nitrogen base agar medium, was chosen 
for preparing the A. restrictus extract. A preliminary study using 
sodium dodecyl sulfate polyacrylamide gel electrophoresis 
showed a difference in protein composition between these two
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A. restrictus extracts (unpubl. data). Therefore, the allergenic 
relationship between the two Aspergillus species was also exam-
ined using the newly prepared extract.
METHODS
Strains
Extracts were prepared from A. restrictus 002, A. fumigatus 
NUMI 1017, and A. alternata 001. A. restrictus 002 and A. 
alternata 001 were obtained from the Public Health Research 
Institute of Kobe City, Japan while A. fumigatus NUM11017 
was provided by the Laboratory of Medical Mycology, Nagoya 
University School of Medicine, Nagoya, Japan.
Extract preparation
Aspergillus restrictus was grown on yeast nitrogen base (YNB) 
agar medium composed of 6.7g of YNB (Difco Laboratories, 
Detroit, MI, USA), 600g of sucrose and 15g of agar per liter at
25℃ for 3 weeks. A. fumigatus was cultivated in YNB liquid
medium consisting of 6.7g of YNB and 30g of sucrose per liter
at 25℃ for 3 weeks in a stationary flask according to the
method described previously.12 A. alternata was cultivated on 
Czapek-Dox agar medium (Gibco Diagnostic, Grand Island,
NY, USA) at25℃ for 11 days. Mycelial mats of A. restrictus and
A. alternata were stripped from each medium using a scalpel, 
and a floating mycelial mat of A. fumigatus was harvested by fil-
tration using cotton gauze. Washings from the mycelial mat of 
A. restrictus were planted on M40Y and Czapek-Dox agars. 
Three weeks later, the gross morphological characteristics and 
the microscopic morphology of the fungal colonies were evalu-
ated to verify their identity and purity.7 Similarly, the identity and 
purity of those of A. fumigatus and A. alternata were confirmed 
using Czapek-Dox and potato dextrose agars.7 These mats, sus-
pended 1:5 weight:volume in Coca's solution, were individually 
homogenized by a Polytron homogenizer (Kinematica, Basel,
Switzerland) for 5 min at4℃. The homogenates were incu-
bated for 72 h at4℃ with gentle stirring and centrifuged at
10000g for 30 min at4℃. The supernatants were dialyzed
against several liters of distilled water overnight at4℃ and then
lyophilized. Protein contents of the extracts were measured with 
a Bio-Rad protein assay kit (Bio-Rad Laboratories, Richmond, 
CA, USA). Bovine serum albumin (BSA; Sigma Chemical, St 
Louis, MO, USA) was used as the protein standard. In a prelimi-
nary trial, we determined the optimal conditions for fungal cul-
ture including the duration of incubation and the culture 
medium. We found that in the conditions adopted here, the 
yield in mycelium of each fungus reached a plateau.
Radioallergosorbent test
Sera from 94 asthmatic Japanese children(meanage-i-s.d.
12.0±3.6 years)and 35 non-atopic patients(8.7±4.8 years)
w re tested by BAST to A. restrictus, A. fumigatus and A. alter-
nat . Serum from patients with aspergillosis was not included. 
BAST was performed by our method.10,12 Briefly, each well of a 
polyvinyl chloride microplate (Sumitomo Bakelite, Tokyo, Japan) 
was filled with 50L of 0.1 mol/L sodium carbonate buffer (pH 
9.8) containing A. restrictus (protein concentration: 50g/mL),
A. fumigatus (20μg/mL)and A. alternata (50μg/mL), and incu-
bated at37℃ for 3 h. After blocking the unoccupied sites of the
wells with human serum albumin (3% w/v, Calbiochem, San 
Diego, CA, USA) in 0.1 mol/L sodium carbonate buffer (pH
9.8),50μLof the serum sample was diluted 1:4 with 0.01 mol/L
phosphate-buffered saline (PBS; pH 7.2) and was incubated 
independently in the antigen-coated wells at room temperature. 
Three hours later, the non-reactive serum was removed, 125I 
radioactivity on the surface of each well was measured in a 
gamma counter (ARC-600, Aloka, Mitaka, Japan) 16 h after the 
application of 50L of 1251-labeled antihuman IgE (Pharmacia 
Diagnostics, Uppsala, Sweden) containing approximately 20 
000 cpm. These assays were performed in duplicate. PAST val-
ues were expressed as standard deviation (s.d.) units of the 35 
non-atopic subjects as follows:
s. d. units = (125I uptake of a sample - mean 125I uptake of nor-
mal controls)/s. d. of 125I uptake of normal controls.
 Our previous study demonstrated the specificity of PAST for 
detecting IgE antibodies binding to allergenic determinants of 
A. restrictus, A. fumigatus and A. alternata using the methods 
of PAST inhibition and serum dilution tests.10
BAST i hibition
Of the 94 serum samples examined by PAST, 13 samples (Table 
1) showed over 5 s.d. units of PAST values for A. restrictus. 
A serum pool was prepared from equal volumes of nine (No. 
1-9) of the 13 sera. The extracts of A. restrictus, A. fumigatus 
and A. alternata, and BSA, used as the inhibiting antigen, were
Table 1. BAST values for Aspergillus restrictus, Aspergillus fumigatus 
and Alternaria alternata in 13 serum samples
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dissolved in PBS (pH 7.2) at serial concentrations ranging from
0.4 to 200μg/mLof protein. These were added to an equal vol-
ume of serum pool and then incubated overnight at4℃. RAST
to A. restrictus, A. fumigatus and A. alternata were carried out as 
described previously. In addition, the 13 serum samples were 
analyzed separately to detect IgE antibodies to allergenic com-
ponents of A. restrictus that were shared with the other fungal 
species. The serum was diluted 1:2 in PBS (pH 7.2) and mixed 
with an equal volume of PBS (pH 7.2) containing each fungal
extract at a concentration of 0, 4, 200 or1 00μg/mLof pro-
tein. After incubation for 16 h at4℃, the A. restrictus BAST was
performed. To exclude the possibility that IgE antibodies bound 
to these fungal extracts without immunologic specificity for bind-
ing antigen, we evaluated the fungal extracts for inhibition of 
RAST to Dermatophagoides farinae and ovalbumin. The mite 
extract, donated by Torii Pharmaceuticals (Tokyo, Japan), and 
ovalbumin (Sigma Chemical) were dissolved at a protein con-
centration of50μg/mLwith 0.1 mol/L sodium carbonate buffer
(pH 9.8). Sera with high titers of IgE antibodies to these antigens, 
after being diluted 1:2 in PBS (pH 7.2), were incubated with 
equal volumes of each of the three fungal extracts dissolved at
serial concentrations ranging from 0.4 to200μg/mLof protein.
The procedures for RAST inhibition as described above were 
then carried out. Results were expressed in terms of percent RAST 
inhibition, which was defined as follows:
100×(radioactive count without inhibition-radioactive count
after inhibition)/(radioactive count without inhibition-back-
ground).
 A level of percent BAST inhibition more than 20% was con-
sidered to be significant.
RESULTS
The yield in mycelium of A. restrictus, A. fumigatus and A. alter-
nata was approximately 36.5, 36.0 and 133.1g of wet weight 
per liter of culture medium, respectively. Their mycelia were not 
misidentified or contaminated by other organisms. The protein 
content of the extracts of A. restrictus, A. fumigatus and A. alter-
nata was 4.99, 8.30 and 2.73%, respectively. In the RAST, sera 
from 27 asthmatic patients showed values over 2 s.d. units in 
A. restrictus RAST, 22 in A. fumigatus BAST, and 33 in A. alter-
nata. In the 35 non-atopic subjects, the mean (s.d.) of BAST val-
ues for A. restrictus, A. fumigatus and A. alternata was 35.4 
(6.78), 30.8 (5.52), and 33.0 (6.30) cpm/well, respectively. Total 
count was 17 873 cpm/well. For the BAST inhibition assays, we 
examined 13 of the 27 sera with over 2 s.d. units of RAST values 
for A. restrictus because the 13 serum samples showed values 
over 5 s.d. units in A. restrictus RAST (Table 1).
  Dose-response curves for RAST inhibition are presented in 
Fig. 1. When the single serum pool was examined, A. restrictus, 
A. fumigatus and A. alternata inhibited their homologous 
BAST by approximately 98% at the maximum concentration of
Fig. 1 Inhibition curves for BAST to (a) Aspergillus restrictus, (b) 
Aspergillus fumigatus and (c) Alternaria alternata. Mycelial extracts of
A.
100μg/mL of protein. Aspergillus restrictus at 100μg/mL inhib-
ited the BAST to A. fumigatus and A. alternata by 88.8% and 
91.6%, respectively. A. fumigatus and A. alternata at the same 
concentration also inhibited their heterologous PAST by more 
than 80%. In contrast, none of these fungal extracts, even at the
maximum concentration of100μg/mL,significantly inhibited
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Table 2. Inhibition of Aspergillus restrictus RAST with extracts of 
A. restrictus, Aspergillus fumigatus and Alternaria alternata in 13 
serum samples with a highly positive BAST to A. restrictus.
the BAST to D. farinae or ovalbumin (<7%). BSA had no 
inhibitory effect on the BAST to any of the fungal species (<7%). 
 When sera with a highly positive BAST to A. restrictus were 
examined separately (Table 2), A. restrictus in amounts that
exceeded 100μg/mL of protein greatly inhibited its homolo-
gous RAST (75.9-94.3% in all 13 subjects). A. fumigatus and 
A. alternata also inhibited the BAST to A. restrictus to a similar 
extent in 10 and 8 of the 11 subjects studied, respectively. In the 
three serum samples without a positive RAST to A. fumigatus 
(No. 7-9), A. fumigatus did not significantly inhibit the 
A. restrictus RAST. A similar result was observed with A. alternata 
in patient No. 9. The sera from patients No. 7 and 8 with a pos-
itive RAST to A. alternata, A. alternata did not show any signifi-
cant inhibition of the A. restrictus BAST.
DISCUSSION 
We have shown that A. fumigatus and A. alternata induced a 
significant inhibition of A. restrictus PAST in most of the sera 
obtained from asthmatic children who showed a highly positive 
PAST to A. restrictus. When a serum pool containing IgE anti-
bodies to A. restrictus was examined, A. fumigatus and A. alter-
nata also substantially inhibited A. restrictus PAST. These 
findings indicate thatA. restrictus shares allergenic components 
with A. fumigatus and A. alternata, and that the cross-reacting 
components may include parts of key allergens of A. restrictus. 
Also, A. restrictus was a potent inhibitor of RAST to A. fumigatus 
and A. alternata in the BAST inhibition tests performed on the 
serum pool. The likelihood that A. restrictus contains parts of 
major allergenic components of A. fumigatus and A. alternata 
is supported by the results of our previous study10 that demon-
strated highly significant correlations between RAST values for
A, restrictus and those for A. fumigatus and A. alternata. 
  The present study confirmed the allergenic cross-reactivity 
between A. restrictus and A. fumigatus as shown in our previous 
study,11 although the protein composition of the A. restrictus 
extracts used in each study differed. We excluded the possibility 
that part of the medium constituents contributed to the aller-
genic relationship, because completely synthetic culture media 
were used in this study. Arruda et al.13 showed that the amino 
acid sequence of Asp f I, a major 18 kDa A. fumigatus aller-
gen,14 is 99% homologous to that of mitogillin, a cytotoxin pro-
duced by A. restrictus. This suggests cross-allergenicity between 
A. fumigatus and A. restrictus. Thus, our results are compatible 
with this sequence data, although there is no evidence that the 
extracts of A. fumigatus and A, restrictus that we used included 
Asp f I or mitogillin, respectively.
  Karr et al.15 demonstrated cross-reactivity among the species 
of A. fumigatus, A. glaucus and A. flavus, but not between the 
genera Aspergillus and Alternaria (i. e. A. alternata). However, 
we have shown thatA. alternata shares common allergens with 
A. fumigatus and A. restrictus. The discrepancy between these 
results may be due to strain differences in allergenic activity of 
the fungi. Indeed, the allergenic variability of different strains 
of A. alternata and A. fumigatus has been previously 
obs ved.16,17 The polyvinyl chloride microplate used in the pre-
sent study may bind a larger amount of polysaccharide aller-
gens than the polysaccharide-based solid phases, which may 
be one explanation for the discrepancy. Several recent studies 
have shown allergenic cross-reactivity among fungal gen-
era.18-22 Our observations are in accord with those results.
 The present study demonstrated that the sera of patients No. 
7-9 with a positive PAST to A. restrictus did not contain IgE anti-
bodies to cross-antigens between A, restrictus and the other 
fungi A. fumigatus and A. alternata, because when these 
sera were tested A. fumigatus and A. alternata did not inhibit 
A. restrictus RAST to any extent. Our results suggest that 
hypersensitivity to A. restrictus, in general, may be induced 
by A. fumigatus and A. alternata as well as by A. restrictus. 
However, occasional cases of hypersensitivity to A. restrictus 
may be induced by A. restrictus alone but not by A. fumigatus 
orA. alternata. 
  There is no firm evidence that A. restrictus is really a cause of 
clinical hypersensitivity. However, its frequent recovery from the 
environment suggests a possibility of the clinical relevance of 
this sp cies in allergic disease. We assume thatA. restrictus may 
initiate the development of fungal allergies in young childhood 
b cause it is commonly present in the home.1-4 A. fumigatus 
and A. alternata presumably are less significant contributors to 
allergic symptoms that occur indoors because their spores do 
n t germinate at the relative humidity found in the typical 
domestic environment.7,23
  In conclusion, we demonstrated a cross-allergenicity among 
A. r strictus, A. fumigatus and A. alternata. This finding will be 
us ful in identifying the fungi involved in fungal allergies.
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CORRIGENDUM 
This article originally appeared in Allergology International Volume 1, Issue 1, 1996. Unfortunately, it included a number of typo-
graphical errors and so the corrected version has been reprinted in full in this issue.
